Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
Comparative use of faecal egg count reduction test, egg hatch assay and beta-tubulin codon 200 genotyping in small strongyles (cyathostominae) before and after benzimidazole treatment.
Veterinary parasitology    September 19, 2002   Volume 108, Issue 3 227-235 doi: 10.1016/s0304-4017(02)00197-8
von Samson-Himmelstjerna G, von Witzendorff C, Sievers G, Schnieder T.A survey on benzimidazole (BZ) resistance in small strongyles was performed on three farms in the tenth region in Chile. Samples from a total of 100 horses were tested using the faecal egg count reduction test (FECRT), the egg hatch assay (EHA) and an allele-specific PCR for the detection of beta-tubulin isotype 1 genes coding for phenylalanine (phe) or tyrosine (tyr) at codon 200. In the past, BZ-type drugs have been used within anthelmintic campaigns on all the three farms. This has predictably led to a high degree of BZ resistance at the Valdivia and Riñihue farms and to a lesser degree at...
Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM    September 11, 2002   Volume 16, Issue 18 1755-1759 doi: 10.1002/rcm.786
Van Eenoo P, Deventer K, Delbeke FT.A sensitive, accurate and precise liquid chromatography/tandem mass spectrometry (LC/MS(2)) method was developed for the quantification of salmeterol in the urine of horses. The method consists of a liquid-liquid extraction with tert-butylmethyl ether and isopropanol at pH 12 after enzymatic hydrolysis. The extracts are analysed using an LC/MS system equipped with an electrospray ionisation (ESI) probe. Method validation showed excellent linearity, specificity, accuracy, precision and intra-laboratory repeatability and reproducibility. The limit of quantitative detection was 0.25 ng/mL and the...
Distribution of orally administered trimethoprim and sulfadiazine into noninfected subcutaneous tissue chambers in adult ponies.
Journal of veterinary pharmacology and therapeutics    September 6, 2002   Volume 25, Issue 4 273-277 doi: 10.1046/j.1365-2885.2002.00418.x
van Duijkeren E, Ensink JM, Meijer LA.The distribution of trimethoprim (TMP) and sulfadiazine (SDZ) into subcutaneously implanted noninfected tissue chambers was studied in healthy adult ponies. Six ponies were given an oral TMP/SDZ paste formulation at a dose of 5 mg/kg TMP and 25 mg/kg SDZ at 12 h intervals for 2 days in order to reach steady-state concentrations. Plasma concentrations and tissue chamber fluid (TCF) concentrations of both drugs were measured at regular intervals during a period commencing 24 h after the last oral administration. The peak concentration of TMP (mean +/- SD) was 2.92 +/- 0.86 microg/mL for plasma a...
Aberrations in uterine contractile patterns in mares with delayed uterine clearance after administration of detomidine and oxytocin.
Theriogenology    September 6, 2002   Volume 58, Issue 5 887-898 doi: 10.1016/s0093-691x(02)00847-6
von Reitzenstein M, Callahan MA, Hansen PJ, LeBlanc MM.An experiment was conducted to determine whether the uterotonic effects of oxytocin, a drug used to treat mares that have a delay in uterine clearance were affected by the sedative detomidine (an alpha2-agonist), a drug used to treat fractious mares. An additional objective was to identify propagation patterns of uterine contractions and determine whether these patterns differed between normal mares and mares with delayed uterine clearance (DUC). Intrauterine pressure was measured in five reproductively normal mares and four mares with DUC during estrus using an 8-F Milar catheter with two dis...
Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-flight mass spectrometry.
Rapid communications in mass spectrometry : RCM    August 31, 2002   Volume 16, Issue 17 1642-1651 doi: 10.1002/rcm.748
Guan F, Uboh CE, Soma LR, Luo Y, Li R, Birks EK, Teleis D, Rudy JA, Tsang DS.Clenbuterol (CBL) is a potent beta(2)-adrenoceptor agonist used for the management of respiratory disorders in the horse. The detection and quantification of CBL can pose a problem due to its potency, the relatively low dose administered to the horse, its slow clearance and low plasma concentrations. Thus, a sensitive method for the quantification and confirmation of CBL in racehorses is required to study its distribution and elimination. A sensitive and fast method was developed for quantification and confirmation of the presence of CBL in equine plasma, urine and tissue samples. The method i...
[Influencing respiratory gas analytical lung function parameters by intravenous injection of clenbuterol in horses with chronic lung diseases].
DTW. Deutsche tierarztliche Wochenschrift    August 7, 2002   Volume 109, Issue 7 295-299 
Sander K, Deegen E, Ohnesorge B.In a placebo-controlled drug study data were collected about flow, volume and expiratory CO2-concentration in 13 horses with chronic obstructive pulmonary disease before and until 2.5 h after intravenous injection of clenbuterol. An ultrasonic flow measuring unit and an infrared-CO2-analyser (Spiroson Scientific) were used. functional deadspace and expiratory mixed volume were calculated. In addition the effect on the partial pressure of oxygen (PaO2) and carbon dioxide (PaCO2) in arterial blood was tested and the alveolo-arterial oxygen difference (AaDO2) determined. The volume of the functio...
Incorrect dose of detomidine.
Journal of the American Veterinary Medical Association    July 18, 2002   Volume 221, Issue 2 192 
Wheat JD.No abstract available
Pharmacokinetics of marbofloxacin in horses.
Equine veterinary journal    July 16, 2002   Volume 34, Issue 4 366-372 doi: 10.2746/042516402776249191
Bousquet-Melou A, Bernard S, Schneider M, Toutain PL.Marbofloxacin is a fluoroquinolone antibiotic expected to be effective in the treatment of infections involving gram-negative and some gram-positive bacteria in horses. In order to design a rational dosage regimen for the substance in horses, the pharmacokinetic properties of marbofloxacin were investigated in 6 horses after i.v., subcutaneous and oral administration of a single dose of 2 mg/kg bwt and the minimal inhibitory concentrations (MIC) assessed for bacteria isolated from equine infectious pathologies. The clearance of marbofloxacin was mean +/- s.d. 0.25 +/- 0.05 l/kg/h and the termi...
Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
Equine veterinary journal    July 16, 2002   Volume 34, Issue 4 360-365 doi: 10.2746/042516402776249173
Carretero M, Rodríguez C, San Andrés MI, Forés P, de Lucas JJ, Nieto J, Waxman S, San Andrés MD, González F.The pharmacokinetic behaviour of marbofloxacin, a new fluoroquinolone antimicrobial agent developed exclusively for veterinary use, was studied in mature horses (n = 5) after single-dose i.v. and i.m. administrations of 2 mg/kg bwt. Drug concentrations in plasma were determined by high performance liquid chromatography (HPLC) and data obtained were subjected to compartmental and noncompartmental kinetic analysis. This compound presents a relatively high volume of distribution (V(SS) = 1.17 +/- 0.18 l/kg), which suggests good tissue penetration, and a total body clearance (Cl) of 0.19 +/- 0.042...
Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse.
Equine veterinary journal    July 11, 2002   Volume 34, Issue 3 242-249 doi: 10.2746/042516402776185985
Toutain PL, Lassourd V.The current performance of analytical techniques used for drug control in horses lead the Regulatory Authorities to decide whether trace levels of drugs legitimately used for therapeutic medication should or should not be reported. Here, we propose a well-ordered and nonexperimental pharmacokinetic/pharmacodynamic approach for the determination of irrelevant drug plasma (IPC) and urine concentrations (IUC). The published plasma clearance is used to transform an effective (marketed) dose into an effective concentration (EPC). EPC is transformed into an IPC by applying a safety factor (SF). This...
Pharmacokinetics of doramectin and ivermectin after oral administration in horses.
Veterinary journal (London, England : 1997)    July 3, 2002   Volume 163, Issue 2 161-167 doi: 10.1053/tvjl.2001.0624
Pérez R, Cabezas I, Godoy C, Rubilar L, Muñoz L, Arboix M, Castells G, Alvinerie M.A study was undertaken in order to compare plasma disposition kinetic parameters of doramectin (DRM) and ivermectin (IVM) in horses after oral administration. Ten crossbreed adult horses, clinically healthy, weighing 380-470 kg body weight (bw) were selected for study. Faecal examinations were performed to determine faecal parasite egg counts. Horses were allocated to two groups of five animals to provide an even distribution considering the variables sex, body weight and faecal egg count. Group I, were treated with an oral paste formulation of IVM at 0.2 mg/kg b/w and Group II, were treated w...
Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2002   Volume 3, Issue 2 189-195 
Lakritz J, Wilson WD, Marsh AE, Mihalyi JE.Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elim...
[Treatment of equine sarcoids with cisplatin in arachid oil: a useful alternative?].
Tijdschrift voor diergeneeskunde    June 21, 2002   Volume 127, Issue 11 350-354 
Spoormakers TJ, Klein WR, van Weeren PR.At the Department of Equine Sciences at Utrecht University a study was performed on the treatment of sarcoids with the cytostatic drug cisplatin. Fourteen horses with 23 sarcoids were treated in the period 2000-2001. Complete regression was seen in 78% of the tumours. No systemic side-effects were encountered. Although treatment was easy to perform, the ALARA (As Low As Reasonably Achievable) principle should be followed when using cytostatics.
Management of gastrointestinal pain.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 133-158 doi: 10.1016/s0749-0739(01)00004-9
Malone E, Graham L.Choice of an analgesic for gastrointestinal pain requires consideration of the cause of the pain, desired duration of pain relief, need for sedation, and potential side effects and toxicity, particularly in light of other drugs being used and effects on the gastrointestinal tract. It is imperative that close monitoring be continued to ensure that surgical lesions or worsening conditions are detected. Recent research in the field may lead to new drugs, drug combinations, and avenues of treatment that minimize the side effects of these drugs while maximizing their efficacy.
Neuromuscular blocking agents.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 181-188 doi: 10.1016/s0749-0739(02)00012-3
Martinez EA.In summary, with proper vigilance, neuromuscular blocking agents can be used safely in anesthetized equine patients to optimize conditions for certain surgical procedures. By appropriate use of neuromuscular monitoring techniques and reversal agents, residual blockade and muscle weakness should be avoided, allowing the horse to recover to standing without difficulty. Research is ongoing to develop the ideal muscle relaxant, one that has a rapid onset, predictable duration and recovery times, and negligible hemodynamic effects. As newer agents become available, they should be evaluated for thei...
Alpha-2 adrenergic agonists as analgesics in horses.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 39-vi doi: 10.1016/s0749-0739(02)00004-4
Daunt DA, Steffey EP.Administration of alpha-2 agonists to horses produces a variety of behavioral effects (sedation, somnolence, analgesia), and physiological effects. One of the most significant beneficial effects of administering alpha-2 agonists is the degree of analgesia they provide. Alpha-2 agonists have been the mainstay of analgesia for colic pain in horses since their introduction to clinical veterinary medicine. The increased potency of the more recently introduced alpha-2 agonists allows the provision of analgesia for conditions not previously relieved by other drugs. Unfortunately, there are significa...
Traditional and non-traditional uses of anesthetic drugs–an update.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 169-179 doi: 10.1016/s0749-0739(01)00008-6
Mama KR.Many new or modified injectable anesthetic techniques are available for use in horses. This increased availability allows the clinician to select the technique most appropriate for the patient and clinical circumstance. The use of sedative and anesthetic drugs in managing a variety of anesthesia-related and unrelated aspects of patient care is also increasing. As we begin to use these techniques in the clinical management of our patients, it is important to remember that, while there are more options, no single anesthetic agent or combination of agents is devoid of undesirable effects. Knowled...
Recent advances in inhalation anesthesia.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 159-168 doi: 10.1016/s0749-0739(01)00007-4
Steffey EP.Both desflurane and sevoflurane offer theoretical and practical advantages over other inhalation anesthetics for horses. The lower solubility of both agents provides improved control of delivery and helps to counteract the confounding influence of the voluminous patient breathing circuit commonly used for anesthetizing horses. The lower solubility should account for faster rates of recovery compared with the older agents; whether or not the quality of recovery differs remains to be objectively evaluated in a broad range of circumstances. The pharmacodynamic effects are, in large part, similar ...
The isomeric metabolites of doxepin in equine serum and urine.
Journal of pharmaceutical and biomedical analysis    June 14, 2002   Volume 29, Issue 1-2 317-323 doi: 10.1016/s0731-7085(02)00069-9
Hagedorn HW, Meiser H, Zankl H, Schulz R.Due to its tranquilizing properties, the tricyclic antidepressant doxepin may be misused as a doping agent in competition horses. Therefore, efficient analytical procedures are required to detect this drug in samples submitted for doping control. To screen for parent doxepin in equine blood and urine, a less specific method has been accepted employing gas chromatography (GC) combined with electron impact (EI) mass spectrometry (MS). The aim of this study was identification of doxepin metabolites providing more specific MS data to verify positives resulting from screening. Thus, after a horse w...
Comparison of pharmacokinetic variables for two low-molecular-weight heparins after subcutaneous administration of a single dose to horses.
American journal of veterinary research    June 14, 2002   Volume 63, Issue 6 868-873 doi: 10.2460/ajvr.2002.63.868
Schwarzwald CC, Feige K, Wunderli-Allenspach H, Braun U.To determine pharmacokinetic variables and to evaluate the influence on clotting times after SC administration of single doses of dalteparin and enoxaparin to horses. Methods: 5 healthy adult horses. Methods: The study was designed as a 4-period crossover study. Each horse received a single SC injection of dalteparin (50 and 100 anti-Xa U/kg) and enoxaparin (40 and 80 anti-Xa U/kg). Plasma anti-Xa activities and clotting times were measured, and pharmacokinetic variables were determined. Absolute and relative maximal prolongation of clotting times was calculated, and correlation between plasma...
Values of urine specific gravity for thoroughbred horses treated with furosemide prior to racing compared with untreated horses. Cohen ND, Peck KE, Smith SA, Ray AC.The distribution of specific gravity values for 2,599 urine samples collected from racing Thoroughbred horses that were known to have received furosemide prior to racing was compared with that for 1,669 urine samples from racing Thoroughbred horses that reportedly had not received furosemide. Values of specific gravity for furosemide-treated horses were significantly lower (P < 0.001) than those for horses that had not received furosemide, and the proportion of horses with urine specific gravity either <1.010 or <1.012 was significantly greater (P < 0.001) among the furosemide-trea...
Cardiovascular effects of romifidine in the standing horse.
Research in veterinary science    May 25, 2002   Volume 72, Issue 2 123-129 doi: 10.1053/rvsc.2001.0533
Freeman SL, Bowen IM, Bettschart-Wolfensberger R, Alibhai HI, England GC.The cardiovascular effects of romifidine, an alpha-2 adrenoreceptor agonist, were investigated in six horses using two doses (80 and 120 microg kg(-1)) in a cross-over study design. Cardiac index and mixed venous oxygenation were significantly decreased at 15 and 30 minutes after both doses of romifidine. Systemic vascular resistance was significantly increased with romifidine (120 microg kg(-1)). Arterial blood pressure increased initially and then gradually decreased; the doses of decrease was significant at 90 and 120 minutes with romifidine 80 and 120 microg kg(-1). There were minimal diff...
Plasma disposition, faecal excretion and in vitro metabolism of oxibendazole following oral administration in horses.
Research in veterinary science    May 11, 2002   Volume 72, Issue 1 11-15 doi: 10.1053/rvsc.2001.0520
Gokbulut C, Nolan AM, McKellar QA.Oxibendazole (OBZ) was administered to eight horses at an oral dose of 10 mg kg(-1) bodyweight each. Parent OBZ could only be detected in plasma at the 0.5 and 1.0 hours post administration sampling times and the mean maximum plasma concentration was 0.008 microg ml(-1). Parent OBZ was detected in faeces between 12 and 72 hours after administration and the highest dry faecal concentration was detected at 24 hours. An unidentified metabolite was detected in plasma between 0.5 and 72 hours. The unidentified metabolite in the plasma of treated horses corresponded to the second eluted metabolite i...
Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.
Journal of veterinary pharmacology and therapeutics    May 10, 2002   Volume 25, Issue 2 135-143 doi: 10.1046/j.1365-2885.2002.00395.x
Knoll U, Strauhs P, Schusser G, Ungemach FR.Olsalazine sodium (Dipentum*) has been used therapeutically against inflammatory bowel disease in human medicine as an alternative to sulphasalazine over the past 20 years. Bacteria in the colon split this prodrug into two molecules of the locally effective 5-aminosalicylic acid (5-ASA). Considering the potential therapeutic use in equine colitis, the pharmacokinetics of olsalazine (OLZ) after single oral administration to six horses at a dosage of 30 mg/kg was investigated. Plasma concentrations of OLZ, 5-ASA, and its main metabolite N-acetyl-5-aminosalicylic acid (Ac-5-ASA) were analysed by ...
Apparent resistance of Parascaris equorum to macrocylic lactones.
The Veterinary record    April 2, 2002   Volume 150, Issue 9 279-281 doi: 10.1136/vr.150.9.279
Boersema JH, Eysker M, Nas JW.No abstract available
Determination of the highest no-effect dose (HNED) and of the elimination pattern for cocaine in horses.
Journal of applied toxicology : JAT    March 29, 2002   Volume 22, Issue 2 117-121 doi: 10.1002/jat.836
Queiroz-Neto A, Zamur G, Lacerda-Neto JC, Tobin T.Cocaine is one of the most widespread illegal stimulants utilized by the human population throughout the world. The aim of this study was to establish the highest no-effect dose (HNED) of cocaine on the spontaneous locomotor activity (SLA) of horses in a behavior chamber, and thereby to determine the maximal acceptable threshold of the urinary drug concentration in horses. Twelve English thoroughbred mares received 0.02, 0.03, 0.04, 0.08 or 0.12 mg kg(-1) cocaine i.v. or saline solution (control). It was noted that doses above 0.04 mg kg(-1) induced a significant increase in SLA (P < 0.05, ...
Detection of morphine in blood and urine samples from horses administered poppy seeds and morphine sulfate orally.
Journal of analytical toxicology    March 28, 2002   Volume 26, Issue 2 81-86 doi: 10.1093/jat/26.2.81
Kollias-Baker C, Sams R.The objective of this study was to determine if the administration of poppy seeds to horses would result in detectable concentrations of morphine in urine and blood samples, as has been shown to occur in humans. In this study blood and urine samples were collected following administration of poppy seeds and morphine sulfate orally to four horses. Urine samples were subjected to enzyme-linked immunosorbent assay (ELISA) for the presence of morphine. All urine samples testing positive by ELISA, as well as plasma samples collected after administration of the 10-g doses of poppy seeds, were analyz...
Effectiveness of a unique dihydropyridine (BAYTG 1000) for prevention of laminitis in horses.
American journal of veterinary research    March 26, 2002   Volume 63, Issue 3 443-447 doi: 10.2460/ajvr.2002.63.443
Hood DM, Brumbaugh GW, Wagner IP.To determine whether a unique dihydropyridine (BAYTG 1000) would be beneficial in preventing laminitis in horses. Methods: 16 clinically normal adult horses. Methods: 8 pairs of horses were used in a controlled double-blind study, using sex- and age-matched horses randomly assigned to treatment or control groups. Horses were subjected to carbohydrate overload to induce laminitis. Treated horses were administered BAY TG 1000 (30 mg/kg, PO, q 24 h) for 3 days. Hoof wall surface temperature (HWST) and lameness were recorded at 4-hour intervals. The HWST was adjusted on the basis of time of onset ...
Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses.
American journal of veterinary research    March 26, 2002   Volume 63, Issue 3 349-353 doi: 10.2460/ajvr.2002.63.349
Peck KE, Matthews NS, Taylor TS, Mealey KL.To compare serum disposition of sulfamethoxazole and trimethoprim after IV administration to donkeys, mules, and horses. Methods: 5 donkeys, 5 mules, and 3 horses. Methods: Blood samples were collected before (time 0) and 5, 15, 30, and 45 minutes and 1, 1.25, 1.5, 1.75, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6, 8, 10, and 24 hours after IV administration of sulfamethoxazole (12.5 mg/kg) and trimethoprim (2.5 mg/kg). Serum was analyzed in triplicate with high-performance liquid chromatography for determination of sulfamethoxazole and trimethoprim concentrations. Serum concentration-time curve for each ani...
Comparison of intraosseous or intravenous infusion for delivery of amikacin sulfate to the tibiotarsal joint of horses.
American journal of veterinary research    March 26, 2002   Volume 63, Issue 3 374-380 doi: 10.2460/ajvr.2002.63.374
Scheuch BC, Van Hoogmoed LM, Wilson WD, Snyder JR, MacDonald MH, Watson ZE, Steffey EP.To establish the route of infusion (IV or intraosseous) that results in the highest concentration of amikacin in the synovial fluid of the tibiotarsal joint and determine the duration of peak concentrations. Methods: 21 horses. Methods: Regional perfusion of a limb on 15 horses was performed. Amikacin sulfate was infused into the saphenous vein or via intraosseous infusion into the distal portion of the tibia (1 g in 56 ml of lactated Ringer's solution) or proximal portion of the metatarsus (1 g of amikacin in 26 ml of lactated Ringer's solution). Amikacin concentrations were measured in seque...
1 53 54 55 56 57 95